Pharmacokinetics and pharmacodynamics of antibacterial peptide NZX in Staphylococcus aureus mastitis mouse model

被引：0
|
作者：
Xueling Zheng
Na Yang
Ruoyu Mao
Ya Hao
Da Teng
Jianhua Wang
机构：
[1] Chinese Academy of Agricultural Sciences,Gene Engineering Laboratory, Feed Research Institute
[2] Chinese Academy of Agricultural Sciences,Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Feed Research Institute
[3] Key Laboratory of Feed Biotechnology,undefined
[4] Ministry of Agriculture and Rural Affairs,undefined
来源：
Applied Microbiology and Biotechnology | 2024年 / 108卷
关键词：
Antimicrobial peptide NZX; Mechanism of action; Pharmacokinetics; Pharmacodynamics; Mouse mastitis model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus
    Rox, Katharina
    Becker, Tim
    Schiefer, Andrea
    Grosse, Miriam
    Ehrens, Alexandra
    Jansen, Rolf
    Aden, Tilman
    Kehraus, Stefan
    Koenig, Gabriele M.
    Krome, Anna K.
    Huebner, Marc P.
    Wagner, Karl G.
    Stadler, Marc
    Pfarr, Kenneth
    Hoerauf, Achim
    PHARMACEUTICS, 2023, 15 (01)
  • [32] Ceftriaxone and methicillin-susceptible staphylococcus aureus: a perspective from pharmacokinetics/pharmacodynamics studies
    Telles, Joao Paulo
    Leme, Rodrigo Cuiabano Paes
    Campos, Michel Leandro
    Ito, Carmen
    Bail, Larissa
    Nogueira, Keite Da Silva
    Tuon, Felipe Francisco
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (09) : 1039 - 1047
  • [33] Methicillin-resistant staphylococcus aureus pneumonia treatment -: Do not confuse pharmacokinetics and pharmacodynamics
    Moine, Pierre
    Bedos, Jean-Pierre
    CHEST, 2007, 132 (03) : 1101 - 1101
  • [34] Evaluation of the effect of serum proteins on the antibacterial activity and pharmacodynamics of ceftaroline against Staphylococcus aureus
    Dalhoff, Axel
    Schubert, Sabine
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (03) : 285 - 287
  • [35] A new high-yielding antimicrobial peptide NZX and its antibacterial activity against Staphylococcus hyicus in vitro/vivo
    Liu, He
    Yang, Na
    Mao, Ruoyu
    Teng, Da
    Hao, Ya
    Wang, Xiumin
    Wang, Jianhua
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 104 (04) : 1555 - 1568
  • [36] Staphylococcus aureus-targeting peptide/surfactant assemblies for antibacterial therapy
    Jiang, Jian
    Xu, Zhilong
    Chen, Jie
    Xu, Ze
    Huang, Ying
    Xi, Juqun
    Fan, Lei
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2022, 214
  • [37] The pathogenesis and control of Staphylococcus aureus-induced mastitis:: study models in the mouse
    Brouillette, E
    Malouin, F
    MICROBES AND INFECTION, 2005, 7 (03) : 560 - 568
  • [38] Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model
    Lister, PD
    CLINICAL INFECTIOUS DISEASES, 2001, 32 : S33 - S38
  • [39] Pharmacokinetics and Pharmacodynamics of a Novel Vancomycin Derivative LYSC98 in a Murine Thigh Infection Model Against Staphylococcus aureus
    He, Peng
    Li, Xin
    Guo, Xiaohan
    Bian, Xingchen
    Wang, Rui
    Wang, Yue
    Huang, Sijing
    Qi, Mengya
    Liu, Yuanxia
    Feng, Meiqing
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1019 - 1028
  • [40] PK/PD Modeling to Assess Rifaximin Clinical Dosage in a Mouse Model of Staphylococcus aureus-Induced Mastitis
    Wang, Honglei
    Chen, Chen
    Chen, Xiaojie
    Zhang, Jingju
    Liu, Yiming
    Li, Xiubo
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
12345